Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window for insiders due to upcoming financial results. It references SEBI regulations on insider trading and specifies the trading window closure dates around the announcement of quarterly and nine-month financial results ending December 31, 2023. The document is short (2250 characters) and serves as a compliance notification rather than containing any financial data or report. It does not include financial statements or detailed results, nor does it announce the results themselves. Therefore, it is an announcement related to regulatory compliance and trading restrictions, fitting best under Regulatory Filings (RNS).
2023-12-29 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the submission of newspaper publications of a Postal Ballot Notice. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30 and 47, which pertain to disclosure of material events and publication of notices. The content is about submitting evidence of the notice publication for a postal ballot, which is a shareholder voting process conducted by mail. There is no financial data, no detailed report, no earnings or management discussion, no voting results, and no other substantive report content. The document is essentially an announcement or notification of the publication of a postal ballot notice, not the notice itself or the results. It is also not a proxy solicitation or voting results announcement. Given the nature of the document as a regulatory compliance announcement to stock exchanges about the publication of a notice, it fits best under Regulatory Filings (RNS). The document length is 15,000 characters, but the content is a formal letter with attachments (newspaper ads) referenced but not included. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-12-29 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of a postal ballot issued by ZIM Laboratories Limited, dated December 28, 2023. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the Companies Act, 2013. The content includes the notice of the postal ballot, explanatory statements, special resolutions to be passed by shareholders, and instructions for remote e-voting. It is not a financial report, earnings release, or management discussion but a formal communication to shareholders to seek approval on specific corporate actions via postal ballot. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions. The document is lengthy (15,000 characters) and contains the full notice and explanatory details, not just an announcement or a brief summary, confirming it is the solicitation document itself rather than a report publication announcement or regulatory filing. Therefore, the appropriate classification is PSI with high confidence.
2023-12-28 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board Meeting held on 23.12.2023. The key agenda item approved was the 'ZIM Laboratories Employee Stock Option Scheme 2023' (ESOS 2023), which requires shareholder approval by way of special resolution. The document includes detailed disclosures about the stock option scheme as required under SEBI regulations. There are no financial statements or comprehensive financial data presented, nor is this a full report. Instead, it is an announcement of a board decision related to employee stock options and compliance disclosures. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement under SEBI Listing Obligations and Disclosure Requirements, not a full report or financial statement. The document length (5418 characters) and content confirm it is not a brief report publication announcement but a substantive regulatory disclosure.
2023-12-23 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates and the consequent stop transfer of those shares. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which deals with share certificate loss and duplicate issuance. The content is an announcement of a corporate action related to share certificates, not a financial report, management change, or earnings release. It is a regulatory compliance notification about share certificate status and stop transfer instructions. The document length is short (2397 characters), and it is not a report but an intimation to the stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-22 English
Board Meeting — ZIM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 23-Dec-2023 to consider ESOP.
Regulatory Filings
2023-12-20 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.